Concepedia
Statistics
Publications
6
Citations
197
H-Index
Active since
2016
Affiliations
Bilkent University(Current)
Hacettepe University
Murat İşbilen is an author at Bilkent University specializing in oncology, medicine, and molecular oncology.
Publications per year
2016–2020
RETRACTED ARTICLE: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
Richard Hill, Patrícia A. Madureira, Bibiana I. Ferreira et al. · Nature Communications · 2017 · 72 citations · Full text
Medicine, Cancer Biology, Oncology +17
A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer
Seçil Demirkol Canlı, İsmail Gömceli, Murat İşbilen et al. · Journal of Cancer · 2017 · 39 citations · Full text
Medicine, Bioinformatics, Oncology +17
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
Michal Lotem, Sharon Merims, Stephen Jay Frank et al. · Journal of Immunology Research · 2016 · 30 citations · Full text
Medicine, Immunology, Oncology +17
Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide
Seyhan Türk, Can Türk, Muhammad Waqas Akbar et al. · PLoS ONE · 2020 · 24 citations · Full text
Medicine, Hematology, Oncology +14
A Stemness and EMT Based Gene Expression Signature Identifies Phenotypic Plasticity and is A Predictive but Not Prognostic Biomarker for Breast Cancer
Muhammad Waqas Akbar, Murat İşbilen, Nevin Belder et al. · Journal of Cancer · 2019 · 17 citations · Full text
1–5 of 6